156 related articles for article (PubMed ID: 25388527)
1. Metabonomic profiling of bladder cancer.
Chan EC; Pasikanti KK; Hong Y; Ho PC; Mahendran R; Raman Nee Mani L; Chiong E; Esuvaranathan K
J Proteome Res; 2015 Feb; 14(2):587-602. PubMed ID: 25388527
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive urinary metabonomic diagnosis of human bladder cancer.
Pasikanti KK; Esuvaranathan K; Ho PC; Mahendran R; Kamaraj R; Wu QH; Chiong E; Chan EC
J Proteome Res; 2010 Jun; 9(6):2988-95. PubMed ID: 20337499
[TBL] [Abstract][Full Text] [Related]
3. Metabonomic diagnosis of bladder cancer: what are the advantages and considerations?
Hong Y; Esuvaranathan K; Pasikanti KK; Yong Chan EC
Bioanalysis; 2015 Nov; 7(21):2727-9. PubMed ID: 26563635
[No Abstract] [Full Text] [Related]
4. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics and bladder cancer.
Hyndman ME; Mullins JK; Bivalacqua TJ
Urol Oncol; 2011; 29(5):558-61. PubMed ID: 21930087
[TBL] [Abstract][Full Text] [Related]
6. Proteometabolomics of bladder cancer: current and future prospects.
Bansal N; Gupta A; Sankhwar SN
Cancer Biomark; 2015; 15(4):339-48. PubMed ID: 25792474
[TBL] [Abstract][Full Text] [Related]
7. Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?
Sapre N; Anderson PD; Costello AJ; Hovens CM; Corcoran NM
Urol Oncol; 2014 Jan; 32(1):48.e9-17. PubMed ID: 24140246
[TBL] [Abstract][Full Text] [Related]
8. UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry.
Zhao YY; Cheng XL; Vaziri ND; Liu S; Lin RC
Clin Biochem; 2014 Oct; 47(15):16-26. PubMed ID: 25087975
[TBL] [Abstract][Full Text] [Related]
9. Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry.
Pasikanti KK; Esuvaranathan K; Hong Y; Ho PC; Mahendran R; Raman Nee Mani L; Chiong E; Chan EC
J Proteome Res; 2013 Sep; 12(9):3865-73. PubMed ID: 23885889
[TBL] [Abstract][Full Text] [Related]
10. Discovery of urine biomarkers for bladder cancer via global metabolomics.
Shi H; Li X; Zhang Q; Yang H; Zhang X
Biomarkers; 2016 Nov; 21(7):578-88. PubMed ID: 27133288
[TBL] [Abstract][Full Text] [Related]
11. Research Progress of Urine Biomarkers in the Diagnosis, Treatment, and Prognosis of Bladder Cancer.
Jin F; Shahid M; Kim J
Adv Exp Med Biol; 2021; 1306():61-80. PubMed ID: 33959906
[TBL] [Abstract][Full Text] [Related]
12. Discovering biomarkers in bladder cancer by metabolomics.
Zhang WT; Zhang ZW; Guo YD; Wang LS; Mao SY; Zhang JF; Liu MN; Yao XD
Biomark Med; 2018 Dec; 12(12):1347-1359. PubMed ID: 30507300
[TBL] [Abstract][Full Text] [Related]
13. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
Rodrigues D; Jerónimo C; Henrique R; Belo L; de Lourdes Bastos M; de Pinho PG; Carvalho M
Int J Cancer; 2016 Jul; 139(2):256-68. PubMed ID: 26804544
[TBL] [Abstract][Full Text] [Related]
15. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
16. Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges.
Burton C; Ma Y
Curr Med Chem; 2019; 26(1):5-28. PubMed ID: 28914192
[TBL] [Abstract][Full Text] [Related]
17. Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: insights into the metabolic effects of growth hormone.
Abd Rahman S; Schirra HJ; Lichanska AM; Huynh T; Leong GM
Growth Horm IGF Res; 2013; 23(1-2):29-36. PubMed ID: 23380306
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the metabolomic study of bladder cancer.
Amara CS; Vantaku V; Lotan Y; Putluri N
Expert Rev Proteomics; 2019 Apr; 16(4):315-324. PubMed ID: 30773067
[TBL] [Abstract][Full Text] [Related]
19. Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces.
Phua LC; Koh PK; Cheah PY; Ho HK; Chan EC
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():103-13. PubMed ID: 24029555
[TBL] [Abstract][Full Text] [Related]
20. [Metabonomics and its applications].
Yang J; Song SL; Castro-Perez J; Plumb RS; Xu GW
Sheng Wu Gong Cheng Xue Bao; 2005 Jan; 21(1):1-5. PubMed ID: 15859320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
